SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-032121
Filing Date
2024-03-08
Accepted
2024-03-08 08:43:20
Documents
17
Period of Report
2024-03-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm248154d1_8k.htm   iXBRL 8-K 33365
2 EXHIBIT 99.1 tm248154d1_ex99-1.htm EX-99.1 53713
7 GRAPHIC tm248154d1_ex99-1img01.jpg GRAPHIC 5664
  Complete submission text file 0001104659-24-032121.txt   330073

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gpcr-20240308.xsd EX-101.SCH 3893
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gpcr-20240308_def.xml EX-101.DEF 27150
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gpcr-20240308_lab.xml EX-101.LAB 37075
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gpcr-20240308_pre.xml EX-101.PRE 25774
18 EXTRACTED XBRL INSTANCE DOCUMENT tm248154d1_8k_htm.xml XML 6113
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

IRS No.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41608 | Film No.: 24732446
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)